Modification in Cortical Activation in Pseudophakic Patients With Visual Difficulties After a Multifocal Implantation
NCT ID: NCT02529098
Last Updated: 2016-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2015-06-30
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Frontoparietal Priority Maps as Biomarkers for MTBI
NCT02251002
Top-Down Attentional Control of Visual-Processing
NCT01087281
Imaging of New Learning in Severe Alzheimer's Disease Patients
NCT01839422
Development of MRI Protocols and Associated Explorations (EEG, NIRS) in Healthy Volunteers
NCT03152539
Functional MRI Study of Attention in Normal Controls and Traumatic Brain Injured Patients
NCT00580918
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
asymptomatic patients
fMRI Asymptomatic patients
fMRI
functional magnetic resonance imaging
symptomatic patients
fMRI patients with visual difficulties
fMRI
functional magnetic resonance imaging
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fMRI
functional magnetic resonance imaging
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Symptomatic patients :
* Symptomatic bilateral visual difficulties for 3 months or more after the intervention which impact the daily activity
Asymptomatic patients :
* No visual complaint for 3 months or more after the intervention
Exclusion Criteria
* Contra indication for fMRI
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Francois Malecaze, professor
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UHToulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12 523 03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.